This inventor holds 1 USPTO granted patent. Top assignee: Smilebiotek Zhuhai Limited. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Hui Ouyang: Innovator in Intraocular Disease Treatment
Introduction
Hui Ouyang is a notable inventor based in Guangdong, China. He has made significant contributions to the field of intraocular diseases, particularly through his innovative patent that addresses age-related macular degeneration (AMD). His work is crucial in the ongoing search for effective treatments for eye diseases.
Latest Patents
Hui Ouyang holds a patent for "Animal models, screening methods, and treatment methods for intraocular diseases or disorders." This patent provides screening methods and animal models related to intraocular diseases such as AMD. It aims to identify candidate therapeutics for treating or preventing eye diseases. The patent also includes compounds and compositions that are useful for killing or inhibiting the growth of microorganisms, which are essential in treating infections associated with such diseases.
Career Highlights
Hui Ouyang is currently associated with Smilebiotek Zhuhai Limited, where he applies his expertise in developing innovative solutions for eye health. His work has the potential to significantly impact the treatment landscape for intraocular diseases.
Collaborations
Hui collaborates with talented individuals such as Yan Zhang and Lai Wei, who contribute to his research and development efforts. Their combined expertise enhances the potential for breakthroughs in the field.
Conclusion
Hui Ouyang's contributions to the treatment of intraocular diseases exemplify the importance of innovation in medical research. His patent and ongoing work at Smilebiotek Zhuhai Limited highlight his commitment to improving eye health and advancing therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile